Constantine Davides
Stock Analyst at JMP Securities
(0.76)
# 3,663
Out of 4,711 analysts
75
Total ratings
26.39%
Success rate
-34.58%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USPH U.S. Physical Therapy | Initiates: Market Outperform | $113 | $91.31 | +23.75% | 1 | Dec 16, 2024 | |
| ADUS Addus HomeCare | Initiates: Market Outperform | $150 | $131.40 | +14.16% | 1 | Dec 16, 2024 | |
| HQY HealthEquity | Maintains: Market Outperform | $105 → $107 | $94.95 | +12.69% | 4 | Dec 10, 2024 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $16 → $8 | $4.91 | +62.93% | 6 | Nov 14, 2024 | |
| AGL agilon health | Downgrades: Market Perform | n/a | $1.97 | - | 2 | Nov 11, 2024 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $66 → $57 | $22.94 | +148.47% | 7 | Oct 22, 2024 | |
| OPCH Option Care Health | Maintains: Market Outperform | $36 → $37 | $22.91 | +61.50% | 2 | Sep 30, 2024 | |
| PGNY Progyny | Downgrades: Market Perform | n/a | $14.34 | - | 3 | Sep 19, 2024 | |
| EVH Evolent Health | Maintains: Market Outperform | $34 → $31 | $11.41 | +171.69% | 4 | Aug 9, 2024 | |
| SLP Simulations Plus | Initiates: Market Perform | n/a | $28.58 | - | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $10.71 | - | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Outperform | $27 | $20.07 | +34.53% | 1 | Dec 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $31.45 | - | 1 | Dec 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $17.91 | - | 1 | Dec 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.49 | +252.35% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $1.65 | +7,475.76% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $27.74 | -45.93% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $17.84 | +26.12% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.40 | +150.00% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.81 | +1,628.40% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.45 | +1,904.45% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $540 | $1.01 | +53,365.35% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $2.63 | +1,420.91% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.68 | +787.71% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $80 | $1.90 | +4,110.53% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $0.82 | +2,339.02% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $3.00 | +2,733.33% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500,000 | $0.66 | +75,757,475.76% | 1 | Mar 28, 2022 |
U.S. Physical Therapy
Dec 16, 2024
Initiates: Market Outperform
Price Target: $113
Current: $91.31
Upside: +23.75%
Addus HomeCare
Dec 16, 2024
Initiates: Market Outperform
Price Target: $150
Current: $131.40
Upside: +14.16%
HealthEquity
Dec 10, 2024
Maintains: Market Outperform
Price Target: $105 → $107
Current: $94.95
Upside: +12.69%
OptimizeRx
Nov 14, 2024
Maintains: Market Outperform
Price Target: $16 → $8
Current: $4.91
Upside: +62.93%
agilon health
Nov 11, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.97
Upside: -
AMN Healthcare Services
Oct 22, 2024
Maintains: Market Outperform
Price Target: $66 → $57
Current: $22.94
Upside: +148.47%
Option Care Health
Sep 30, 2024
Maintains: Market Outperform
Price Target: $36 → $37
Current: $22.91
Upside: +61.50%
Progyny
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $14.34
Upside: -
Evolent Health
Aug 9, 2024
Maintains: Market Outperform
Price Target: $34 → $31
Current: $11.41
Upside: +171.69%
Simulations Plus
Jul 16, 2024
Initiates: Market Perform
Price Target: n/a
Current: $28.58
Upside: -
Jul 10, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $10.71
Upside: -
Dec 6, 2023
Initiates: Market Outperform
Price Target: $27
Current: $20.07
Upside: +34.53%
Dec 6, 2023
Initiates: Market Perform
Price Target: n/a
Current: $31.45
Upside: -
Dec 6, 2023
Initiates: Market Perform
Price Target: n/a
Current: $17.91
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.49
Upside: +252.35%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.65
Upside: +7,475.76%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $27.74
Upside: -45.93%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $17.84
Upside: +26.12%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.40
Upside: +150.00%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.81
Upside: +1,628.40%
Apr 19, 2023
Reiterates: Buy
Price Target: $9
Current: $0.45
Upside: +1,904.45%
Apr 13, 2023
Reiterates: Buy
Price Target: $540
Current: $1.01
Upside: +53,365.35%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $2.63
Upside: +1,420.91%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.68
Upside: +787.71%
Sep 28, 2022
Maintains: Buy
Price Target: $140 → $80
Current: $1.90
Upside: +4,110.53%
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $0.82
Upside: +2,339.02%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $3.00
Upside: +2,733.33%
Mar 28, 2022
Initiates: Buy
Price Target: $500,000
Current: $0.66
Upside: +75,757,475.76%